TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Overall, findings from this inter-laboratory study provided crucial data to support TRPM3 as a potential biomarker for research and diagnosis of ME/CFS, as the first large sample size study investigating TRPM3 disruption in people diagnosed with ME/CFS compared to HC.